| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Leversage Jill is a Director at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $412K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sell | 5,610 | $5.74 | $32,201.40 | -30.3% | +15.2% | +49.2% | |
| May 23, 2023 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sale+OE | 4,815 | $11.26 | $54,216.90 | -20.6% | -15.6% | -51.1% | |
| Dec 13, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 1,600 | $20.04 | $32,064.00 | +43.2% | -49.5% | -76.1% | |
| May 11, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 2,500 | $10.96 | $27,389.25 | +208.3% | +39.7% | -14.7% | |
| Jan 29, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 1,600 | $16.03 | $25,648.00 | New | - | - |